Which of the following is a caution for the use of intranasal decongestants?

Prepare for your Allergic Rhinitis, Asthma, and COPD Therapeutics Test. Revise with flashcards and multiple-choice questions, each with hints and explanations. Ensure you are ready for your exam!

The use of intranasal decongestants is cautioned primarily for individuals with hypertension due to their potential systemic effects. Intranasal decongestants work by constricting blood vessels in the nasal passages to reduce swelling and congestion. However, this vasoconstrictive action can also lead to increased blood pressure, which poses a significant risk to individuals already suffering from hypertension. Consequently, it's essential for people with this condition to approach the use of these medications with caution, as they could exacerbate their existing health problems.

In contrast, while some concerns exist regarding pregnancy, asthma, and diabetes, they do not carry the same level of caution associated with hypertension. Pregnant individuals may need to avoid certain medications but typically have alternative options available. Asthma patients generally do not face direct contraindications when using intranasal decongestants, although caution may be warranted based on individual reactions. Those with diabetes must monitor their overall health but are not specifically cautioned against the use of intranasal decongestants unless there are other complicating factors. Thus, hypertension stands out as the primary concern when considering the safety of intranasal decongestants.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy